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Introduction
Tuberculosis evolution and treatment response are de-
termined by the mycobacteria virulence, protective mecha-
nisms and the organism’s capacity to fight against the ag-
gression of the oxidative stress through the antioxidant 
defense [3]. The oxidative stress (OS) is caused by the im-
balance between the systemic manifestation of the reactive 
oxygen species (ROS) and the biological system’s ability to 
detoxify them and to repair the resulting damage [7]. ROS 
are produced from molecular oxygen following the normal 
cellular metabolism. As well as, numerous exogenous fac-
tors are the sources of the ROS: smoking, ozone exposure, 
hyperoxia, ionizing radiation, intoxication with heavy met-
als and some drugs. ROS are divided into 2 groups: free rad-
icals and non-radicals. From the group of the free radicals 
there are: O2- (superoxide radical), OH-(hydroxyl radical), 
H2O2 (hydroxyl peroxide), ROOH (organic hydroperoxide), 
RO- and ROO- (alkoxy and peroxy radicals), HOCl (hypo-
chlorus acid) and ONOO- (peroxynitrite) [22]. The biggest 
physiological damage determines superoxide radical (O2-), 
hydroxyl radical (OH-) and hydroxyl peroxide (H2O2). At 
the biochemical level severe OS lowers the effectiveness of 
the enzymatic and non-enzymatic antioxidant defense [7]. 
The disturbances in the normal redox system cause toxic ef-
fects through the peroxidation of the cellular DNA, proteins, 
lipids, carbohydrates and other biological macromolecules 
[22]. Mild OS causes cell apoptosis and severe OS– necrosis 
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Abstract
Background: The oxidative stress biomarkers in tuberculosis were studied, but the differences between the pulmonary drug susceptible and drug resistant 
forms were not identified.
Material and methods: A prospective, case-control study, which included 51 patients, distributed in 2 groups: the 1st study group (N=24 new cases with 
drug susceptible tuberculosis) and the 2nd group (N=27 new cases with MDR-TB) similar distributed according to the sex and age were compared with a 
control group constituted from 36 healthy persons. The intensity of the oxidative stress was appreciated through the serum concentration of the advanced 
oxidation protein products, lysosomal marker N-acetil-β-D-glucosaminidase, advanced glycation end-products (AGEs). The antioxidant defense was 
assessed through the total serum antioxidant activity, the activity of the glutathione enzymes and proteins with antioxidant role.
Results: In MDR-TB carbohydrate peroxidation biomarker versperlysines-like AGEs was diminshed, as well as the serum antioxidant defense assessed 
through CUPRAC method. In drug susceptible tuberculosis was established the elevation of the protein peroxidation, high lysosomal membrane damage 
and increased acute phase protein – ceruloplasmine. Antioxidant enzyme glutathione S-transferase had lower activity in both types of tuberculosis which 
contributed to the increasing of the γ-glutamyltransferase. 
Conclusions: The oxidative stress level was more elevated in drug susceptible tuberculosis and antioxidant defense was more impaired in the MDR-TB 
group. The antioxidant biomarker – glutathione S-transferase activity, was lower in both types of tuberculosis which increased the γ-glutamyltransferase 
activity. The polymorphism assessment of the glutathione S-transferase enzyme is important for the individualized therapy and reducing the toxicity of 
the anti-tuberculosis treatment.
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and functional impairment. Many pathological disturbanc-
es and diseases are attributed to the OS: cancer, atheroscle-
rosis, hyperthension, respiratory distress syndrome, chronic 
obstructive pulmonary disease, asthma, pulmonary fibrosis 
and neurological disturbances [6, 8, 18, 23]. Advanced oxi-
dation protein products (AOPP) are considered novel mark-
ers of the OS [5]. They result from the interaction between 
the chlorine oxidants (chloramines and hypochlorus acid) 
with plasmatic proteins [26]. AOPP are carried by oxidized 
plasma proteins, especially albumin, are excreted by the kid-
neys and the highest concentrations were identified in pa-
tients with severe chronic renal failure, hyperparathyroid-
ism and continuous treatment with calcium and vitamin D 
[24]. High concentrations of the AOPP are correlated with 
high level of the advanced glycation end products (AGEs), 
resulting from the non-enzymatic glycation of the proteins, 
lipids and nucleic acid, following the “Maillard” chain of 
reaction [10]. High AGEs concentration is identified in pa-
tients with diabetes mellitus and represents a marker of the 
hyperglycemia, non enzymatic glycosilation of the proteins 
and excessive activation of the polyol way [18]. Close corre-
lation was found between high levels of AOPP and AGEs in 
monocyte-mediated inflammatory processes [3].
Lysosomal enzymes are mediators of the tissue damage 
in any type of inflammation [3].     
N-Acetyl-β-glucosaminidase (NAG) is a high molecu- 
lar-weight (~140 kDa) hydrolytic lysosomal enzyme, iden-
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tified in many tissues. It breaks chemical bonds of glyco-
sides and amino sugars that form structural components 
of the tissues and is localized in various parts of the cell, 
including the cell membrane. There are two main isoen-
zymes: isoenzyme-A and isoenzyme-B, being different in 
their heat sensitivity and stability. Isoenzyme-A is con-
tained in the azurophilic granules of polymorphonuclear 
leukocytes and is excreted during the exocytosis. Isoen-
zyme-B is localized in the lysosomal membrane and is 
excreted during lysosomal damage [25]. High activity of 
NAG is a marker of tissue damage, inflammation and loss 
of lysosomal integrity [25].
The antioxidant system is composed by the hydrophilic 
antioxidant compounds identified in the cytoplasm and 
blood serum, as well as the hydrophobic compounds, which 
are localized in the biological membranes [7]. Gluthatio-
ne (GSH) is the most important antioxidant in animals, 
plants and bacteria. It prevents the damage of the cellular 
components produced by ROS and heavy metals. GSH re-
duces disulfide bonds formed within cytoplasmic proteins 
and cysteines serving as an electron donor. In the redox 
process the GSH is converted in its oxidized form, called 
glutathione disulfide (GSSG.) Once oxidized, the GSH can 
be reduced back by glutathione reductase, using NADPH as 
an electron donor. The ratio between reduced glutathione 
(GSH) to oxidized glutathione (GSSG) within cells is used 
as a measure of the cellular oxidative stress [19]. Glutathi-
one S-transferase (GST) is a cytosolic, mitochondrial and 
microsomal enzyme, involved in the detoxification of the 
xenobiotics through the conjugation catalysis of the reduced 
glutathione in mercapturic compounds [11]. Assessment of 
the GST activity is a diagnostic tool of the OS and efficiency 
of the detoxification mechanisms related to GST [1, 14, 16]. 
The γ-glutamyltransferase (γ-GPT) is a key-enzyme of the 
γ-glutamyl cycle, which catalyses the transfer of the γ- glu-
tamyl group from the glutathione to other amino acids [1, 
4]. It is localised in the cell’s membrane, and the enzyme’s 
active centre at the exterior cell’s border. It has a major role 
in the detoxification of the inflammatory mediators (cyto-
kines, acute phase proteins), carcinogenic substances and 
toxine [3]. The synthesis of the γ-GPT is induced by drugs, 
colestasis, alcohol consumption, hepatic tumors and cir-
rhosis [1]. Actually, the γ-GPT is considered advanced bio-
markers of the OS [9]. 
Drug susceptible TB is treated with first line anti-tuber-
culosis drugs: isoniazid, rifampicin, ethambutol, pirazin-
amide and streptomycin [27]. Tuberculosis determined by 
the multidrug resistant strains (MDR-TB) is treated during 
18-24 months with 2nd line antituberculosis drugs according 
to the drug susceptibility test [28]. The standard treatment 
for MDR-TB consists in injectable antibiotics – aminogly-
cozides (kanamycin, amikacin or capreomycin) and orally 
administrated anti-tuberculosis drugs: fluoroquinolones 
(levofloxacin, moxifloxacin or gatifloxacin), ethionamide, 
prothionamide, paraaminosalicylic acid and cycloserine) 
[28]. The rate of adverse drug events, usually correlated with 
the OS is much higher in patients treated with second line 
anti-TB drugs, patients with TB-HIV co-infection, than in 
those treated with first line drugs [12, 26]. The aim of the 
study was the assessment of the oxidative stress biomarkers 
and antioxidant system compounds in patients with pulmo-
nary drug susceptible and drug resistant tuberculosis and 
their comparison with a group of healthy persons.
Material and methods
It was realized a prospective research evaluating the 
biochemical markers of the OS in 87 cases, from which 24 
were new cases with drug susceptible pulmonary tubercu-
losis included in the 1st study group and 27 were MDR-TB 
patients which were included in the 2nd study group. The 
groups were compared between them and were compared 
with a control group (CG) composed from 36 healthy per-
sons assessed according to the clinical and biochemical 
criteria. The research reported ethics committee approval 
(nr. 14 of 21/11/2017) and patients’ consent was obtained. 
Patients were diagnosed in the medical specialized institu-
tions of Chisinau during the period 01.01.2016-31.08.2016. 
Included criteria in the study group were: age more than 18 
years old, patient diagnosed with pulmonary tuberculosis, 
new case type, the diagnosis confirmed through the conven-
tional microbiological methods (microbiological examina-
tion and molecular genetic test of the sputum). The study 
investigation schedule included information about sex, age, 
radiological aspects, microbiological patient’s status, treat-
ment regimen and adverse drug reactions. The included 
criteria in the control group were: age more than 18 years 
old, conditioned healthy persons according to the clinical 
examination, blood test (complete blood count) and bio-
chemical tests (liver transaminases, bilirubin test, hepatitic 
virus serological tests, HIV serology). 
The biochemical investigation of patients was performed 
during the intensive phase of the treatment. The 36 healthy 
persons from the control group were investigated in ambu-
latory conditions. The estimation of the biochemical indices 
in the serum was performed using the methods with mi-
croquantities of the evaluated material. The samples were 
analysed by spectrophotometry in the maximum standard-
ization conditions. Total proteins were determined using 
the Lowry modified method [9]. The AOPP were analysed 
according to the Witko-Sarsat V. modified method [24]. The 
AGEs were quantified in two types: pentosidine-like AGEs 
and vesperlysines-like AGEs [17, 21]. The micromethod 
was based on the fluorescence measure of the intensity of 
the samples diluted in the phosphate tampon at λexc 335 
nm, λem 385 nm (quantification of the pentosidine-like 
AGEs) and at λexc 370 nm, λem 440 nm (quantification of 
the vesperlysines-like AGEs) according to the Sero L. modi-
fied method [10, 20]. 
The determination of the total antioxidant activity 
(tAOA) was performed using two procedures: 1) method 
based on the degradation of the 2,2-azino-bis (3-ethylben-
zothiazoline-6-sulfonic acid (ABTS) radical at the interac-
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tion with serum compounds with the antioxidant proper-
ties and measure of the decreasing absorbance at 734 nm 
[9]; 2) method CUPRAC (Cupric Ion Reducing Antioxidant 
Capacity) based on the reducing capacity of the cupric ion 
through the captation of the hydroxyl radical [20].
The serum antioxidant capacity was assessed by the dos-
age of the glutathione enzymes (GST and γ-GTP) activity 
using the analysis kits of the Eliteh (France) producer, ac-
cording to the attached instructions.
Statistical analysis was carried out by the comparative 
assessment of the quantitative and qualitative peculiarities 
of the selected patients using the Microsoft Excel XP pro-
gramme. Accumulated material was systematized in simple 
and complex groups. For the testing of significant differ-
ences between the studied indices of the compared samples 
it was performed the statistic non-parametric t test and the 
significance threshold p<0.05.
Results
By distributing patients according to the biological char-
acteristics was established a similar rate of men and women 
in all three groups, with the predomination of men in the 
same proportion, which permitted the comparability of the 
results. The same proportion of young persons, aged less 
than 44 years old, was established in all groups. All enumer-
ated conditions permitted the comparability of the labora-
tory data (tab. 1).
Table 1
Segregating patients in sex and age groups
Biological 
segregation
parame-
ters
1st SG 
(N=24)
2nd 
SG(N=27)
CG (N=36)
N (%) N (%) N (%)
Sex stratifica-
tion
Men 14 (58%) 18 (67%) 24 (67%)
Women 10 (42%) 9 (33%) 12 (33%)
Stratification in 
age groups
18-44 
years
18 (75%) 21 (77%) 29 (81%)
≥45 years 6 (25%) 5 (23%) 7 (19%)
Detected by passive way, using standard tools (microbi-
ological examination and chest X-ray) for the investigation 
of the symptomatic patients were 15 (62%) cases of the 1st 
SG and 17 (63%) cases of the 2nd SG. The main proportion 
of both study groups was constituted from the patients with 
pulmonary infiltrative TB: 22 (91%) in the 1st SG and 24 
(89%) in the 2nd SG. Radiological investigations identified 
lung destruction in all selected TB patients. Microbiologi-
cal status was positive in all patients and drug susceptibil-
ity testing permitted their distribution according to the ob-
tained drug resistance results. Standard treatment for drug 
susceptible TB was administrated in patients from the 1st SG 
and standard treatment for MDR-TB in patients from the 
2nd SG. There were no major adverse drug reactions identi-
fied in the selected patients.
Biomarkers of the OS constituted the blood concentra-
tion of the AOPP, the activity of the NAG, the concentration 
of the pentosidine-like AGEs and vesperlysines-like AGEs. 
Assessing the concentration of the AOPP was established 
a statisticaly higher level in the 1st SG compared with the 
CG (p<0,05) and unsignificantly higher concentration in 
the 2nd SG comparated with the CG. No differences were es-
tablished between the study groups. The NAG activity was 
significantly higher in the 1st SG compared with the 2nd SG, 
as well as compared with the CG. In the 2nd SG the NAG 
activity was similar with the results obtained for the CG. 
The concentration of the pentosidine-like AGEs was sig-
nificantly lower in the 1st SG compared with the 2nd SG and 
compared with the CG. The level of vesperlysines-like AGEs 
was significantly lower in the 2nd SG compared with the 1st 
SG and compared with the control group (p<0,001). Data 
are shown in the table 2.
The antioxidant defense was evaluated through the 
glutathione-related enzymes, non-enzymatic proteins and 
total antioxidant activity (tAOA) of the serum. The se-
rum level of the glutathione-S-transferase (GST) was sig-
nificantly lower in both study groups compared with the 
control group at the same statistical level. The activity of 
γ-glutamyltranspeptidase (γ-GPT) was significantly in-
creased in both study groups in comparison with the control 
Table 2
Indices of the oxidative stress
Oxidative system Parameter 
1st SG (N=24) 2nd SG(N=27) CG (N=36)
M±SE (%) M±SE (%) M±SE (%)
Proteic peroxidation AOPP μMol/l 45.07±22,15(131%) □ 38.42±15,77(111%) 34.349±3,58 (100%)
NAG mMol/s.L 87.79±42.17(133%)■□ 66.29±22.27(101%) 65.88±18.63(100%)
Carbohydrate peroxidation Pentosidine-like AGEs 140,79±73,63(66%) ○ 216,56±151,64(100,8%) 208,5±16,27(100%)
Vesperlysines-like 
AGEs
469,89±166,13(93%)○● 273,82±106,83(62%) ◊ 343,2±49,63(100%)
Note: AOPP – advanced oxidation protein products; NAG – N-acetyl-β-D-glucosaminidase; AGEs – Advanced glycated end-products. The percentage 
was assessed comparing the study groups with the reference value of the control group (100%). Comparison between study groups ● p<0.001 ■ p<0.05; 
comparison between the 1st SG and CG ○ p<0.001 □ p<0.05 ; comparison between the 2nd SG and CG ◊< 0.001.
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group. The index was significantly higher in the 2nd SG com-
pared with the 1st SG. The total antioxidant activity (tAOA) 
of the serum assessed through the ABTS and CUPRAC 
methods established different results. tAOA evaluated us-
ing ABTS method was nonsignificantly lower in both study 
groups compared with the CG, without differences between 
groups. Assessing tAOA using CUPRAC method, was iden-
tified a significantly higher level in the 1st SG and a mild 
decreasing tendency in the 2nd SG compared with the CG. 
Comparing the groups of patients it was identified a sta-
tistically higher level of the tAOA using CUPRAC method 
in the 1st SG compared with the 2nd SG. The concentration 
level of the ceruloplasmine, known as a protein of the acute 
phase, with antioxidant role was detected significantly high-
er in the study groups compared with the CG. The concen-
tration of the total serum proteins (albumin, α1, α2, β and γ 
globulins), which include and those with an antioxidant role 
was lower in CG compared with both study groups. No dif-
ferences were identified between study groups (tab. 3).
Discussion
Distributing the patients, according to the sex and age, 
it was determined the predomination of the men at repro-
ductive age (18-44 years) in both study groups, as well as in 
the control group, which allowed the comparability of the 
results. 
Two thirds of both study groups were detected by us-
ing standard microbiological examination and chest X-ray 
investigation. Similar data were obtained in the national 
studies. The majority of both study groups was diagnosed 
with pulmonary infiltrative TB with lung destruction. Mi-
crobiological status was positive in all patients and drug sus-
ceptibility testing permitted their distribution according to 
the obtained drug resistance results. Standard treatment for 
drug susceptible TB was administrated in patients from the 
drug susceptible group and standard treatment for MDR-
TB in patients from the 2nd SG. The regimens were used ac-
cording to the WHO recommendations [27, 28].
The biomarker of the OS – the concentration of the AOPP 
was higher in the drug susceptible TB group, compared with 
the MDR-TB group and healthy group demonstrating a 
higher level of the oxidative damage and protein catabolism 
in the 1st SG. In the speciality literature, comparable studies 
about AOPP concentration in patients with drug suscepti-
ble and MDR-TB have not been identified. The serum con-
centration of the pentosidine-like advanced glycation end-
products determined a significantly lower concentration in 
patients with drug susceptible tuberculosis compared with 
the patients with MDR-TB and healthy group. The results 
confirmed the state of organism’s starvation and exacerba-
tion of catabolic processes assessed through the AOPP dos-
age. The serum level of vesperlysines-like advanced glyca-
tion end-products was much lower in the group of MDR-TB 
patients, compared with the drug-susceptible group. Both 
biomarkers of the carbohydrate peroxidation demonstrated 
the disturbances in the glycemic metabolism, which cannot 
be compared with the data issued from the international 
studies where enrolled diabetic patients with tuberculosis 
were. The high activity of the NAG is considered a biomark-
er of the xenobiotic-induced lysosomal membrane damage. 
The activity level was significantly higher in the drug sus-
ceptible tuberculosis group compared with the patients with 
MDR-TB and healthy group. It demonstrated the sustained 
oxidative damage of the leukocytes by the acute inflamma-
tory process. No similar studies were found in the interna-
tional review. The biomarker of the antioxidant defense – 
total antioxidant activity assessed using ABTS method was 
mildly decreased in the groups of tuberculosis-patients; on 
the other hand, CUPRAC method established contradicto-
Table 3
Indices of the antioxidant defense
Antioxidant system Parameter 
1st SG (N=24) 2nd SG(N=27) CG (N=36)
N (%) N (%) N (%)
Glutathione-related enzymes Glutathione S-transferase nMol/s. L 16.650±5,98
(77%) ○
16.222±8,52
(75%) ◊
21.5±6.75
(100%)
γ-Glutamyltransferase U/l 62.95±6.56
(147%)∆
78.24±3.58
(183%)●
427±7.02
(100%)
Total antioxidant activity 
(tAOA)
Method ABTS mMol/l 0.65±0.03
(91%)
0.67±0.03
(94%)
0.71±0.004 (100%)
Method CUPRAC mMol/l 1.42±1.49
(276%) ∆●
0.59±0.47
(88%)
0.52±0.04 (100%)
Non-enzymatic antioxidants Ceruloplasmine mg/ml 911.31±210.70
(125%) □
852.101±256.1
(117%)
724.3±27.8
(100%)
Total protein 59.21±4.95 
(103%)
59.53±2.18
(103%)
57.1±2.3
(100%)
Note: The percentage was assessed comparing the study groups with the reference value of the control group (100%). Comparison between study groups 
● p<0,001 ■ p<0.05; comparison between the 1st SG and CG ∆ p<0.001○ p<0.01 □ p<0.05; comparison between the 2nd SG and CG ◊< 0.01.
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ry results. So, in the drug susceptible group AOA was three 
times higher and in MDR-TB group it was slightly decreased 
compared with the healthy group. It could be explained by 
different components of the serum involved in the antioxi-
dant defense identified through the ABTS and CUPRAC 
methods. The concentration of the ceruloplasmine, acute 
phase proteine with antioxidant role, was higher in the drug 
susceptible group compared with the MDR-TB and control 
group, and confirmed a higher toxic damage due to acute 
inflammatory process, as did the lysosomal marker (NAG), 
ceruloplasmine and advanced oxidation protein products.
The activity of the glutathione S-transferase enzyme 
(GST) was significantly diminished in the group of pa-
tients with tuberculosis. The literature data correlated the 
epigenetic disturbances with the low level of the GST gene 
expression, especially of the isoformes associated with the 
hepatotoxicity of the anti-tuberculosis drugs [15]. In conse-
quence, the level of γ- glutamyltransferase at patients with 
both types of tuberculosis was significantly increased.
Conclusions
1. In patients with drug susceptible tuberculosis was es-
tablished the increased level of the protein peroxida-
tion, lysosomal membrane damage and acute phase 
protein.
2. In patients with MDR-TB were identified severe dis-
turbances of the carbohydrate peroxidation evaluated 
through the verspelysines-like AGEs and reduced an-
tixodant defense assessed through CUPRAC method.
3. Enzymatic antioxidant defense – glutathione S-trans-
ferase activity, was lower in both types of tuberculosis 
which contributed to the increasing of the γ- glutamyl-
transferase during the antituberculosis treatment.
4. The polymorphism assessment of the glutathione S-
transferase enzyme is important for the individualized 
therapy and reducing the toxicity of the anti-tubercu-
losis treatment.
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